Instytut Diagnostyki Molekularnej Diagmolsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-06-20
Share capital
5 000,00 PLN
Activity description

Instytut Diagnostyki Molekularnej Diagmol is a company that specializes in advanced genetic diagnostics, offering certified tests for early disease detection, personalized prevention, and effective treatment selection. Their services include whole exome sequencing (WES) and non-invasive prenatal testing (NIPT), along with personalized oncology and investigations into miscarriage causes. They provide quick results and reliable interpretation by experienced specialists.

Registered address
ul. Gwiaździsta 62/12/2, 53-413 Wrocław, Poland
Website
diagmol.plWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-27343-55096-WSBWS-16

Financials

The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue
This companyUSD 46.28kMedianUSD 92.16kAverageUSD 1.47m
Net profit
This companyUSD -45.05kMedianUSD 2.46kAverageUSD 170.36k
Operating costs
This companyUSD 88.25kMedianUSD 85.23kAverageUSD 1.19m
Assets
This companyUSD 2.18kMedianUSD 40.76kAverageUSD 1.02m

Bank accounts

Registered as a VAT taxpayer on 2023-06-23. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Aneta Emilia Ganc — Management Board Member
Łukasz Madej — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Aneta Emilia Ganc (46)
50$675.3150%
Łukasz Madej (40)
50$675.3150%

Beneficial owners

Person
Aneta Emilia Ganc (46)
Łukasz Madej (40)

Competitors

Name
Ur-Es Medsp. z o.o.
Friszsp. z o.o.
Promindsp. z o.o.
Diagnosteosp. z o.o.
Lege.Clinicsp. z o.o.
Onkomedicasp. z o.o.
Zintegrowanisp. z o.o.
TMRWsp. z o.o.
Langmedicosp. z o.o.
Esdent Diagnostykasp. z o.o.

Change history

DateEvent
2024-11-18PKD change
2024-08-26Address change
2023-06-20Entered in the register

FAQ

Last updated: 2026-07-17